Lyell Immunopharma, Inc. (LYEL)
24.55
+0.25
(+1.03%)
USD |
NASDAQ |
Jan 09, 16:00
24.56
+0.01
(+0.04%)
After-Hours: 20:00
Lyell Immunopharma Accounts Payable (Quarterly): 2.568M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Insmed, Inc. | 79.59M |
| Nektar Therapeutics | 15.56M |
| GT Biopharma, Inc. | 0.769M |
| Ionis Pharmaceuticals, Inc. | 14.33M |
| Regeneron Pharmaceuticals, Inc. | 903.80M |